Ayahuasca in Colombia vs Peru: A Complete Comparison Guide

Yagé vs. Ayahuasca: Why Colombia Calls It Something Different

The same vine, but not the same word.

Yagé and ayahuasca refer to brews built around the same backbone vine, Banisteriopsis caapi. Both contain the harmala alkaloids harmine, harmaline, and tetrahydroharmine, which make oral DMT psychoactive by inhibiting monoamine oxidase. But the two names track to different geographies, different tribal languages, and in many cases a different secondary plant.

In Peru, the second plant is almost always Psychotria viridis, the shrub locals call chacruna, which carries the DMT load. In the Colombian Putumayo and the Vaupés, the second plant is more often Diplopterys cabrerana, called chagropanga or chaliponga. Mass-spectrometry analysis of brews from both regions confirms that DMT concentrations in Diplopterys-based ayahuasca are comparable to or higher than the chacruna-based version (Chambers et al., 2020). Bronwen Gates’ 1982 monograph for the New York Botanical Garden formally separated Diplopterys cabrerana from Banisteriopsis after decades of taxonomic confusion (Gates, 1982).

The word ayahuasca is Quechua, from aya (spirit, soul, dead) and waska (rope or vine). The word yagé came north with the brew through the Tukanoan and Cofán peoples of the upper Amazon and is the standard term across Colombian indigenous traditions. The Inga, Kamëntsá, Cofán, and Siona use yagé. The Cubeo say kahpí. Reichel-Dolmatoff documented the Desana of the Vaupés using the word in cosmological registers across his fieldwork from the 1960s and 1970s (Reichel-Dolmatoff, 1975).

The practical implication is straightforward. If you are researching what is sometimes presented as a single Amazonian medicine, you are actually looking at a regional family of preparations and lineages. The term someone uses tells you something about where they trained and which tradition they hold to. For the deeper picture of how this medicine moves through one of Colombia’s central yagé traditions, see our Kaméntsá ayahuasca lineage guide.

Indigenous Traditions: Shipibo, Inga, Cofán, Pastos, and Kogi

Same plants, different elders, different rooms.

Peru’s commercial ayahuasca scene was shaped, in large part, by the Shipibo-Konibo of the central Ucayali. Their songs, called icaros, are how the work moves: the maestra or maestro sings the geometric patterns of the medicine into the body of the participant. An observational study of Shipibo ceremonial use found sustained well-being effects across regular participation, with low rates of acute psychiatric adverse events when ceremonies followed traditional protocols (Gonzalez et al., 2021). Q’ero healers from the Andes also operate in the Peruvian space, although their core ceremonial frame is Andean rather than Amazonian. Outside these lineages, a sizable mestizo or vegetalismo tradition has grown around Iquitos since the rubber-boom era, drawing on indigenous teaching and on plants treated as teachers in their own right.

Colombia’s lineages are older in the published record and more plural on the ground. The Inga and Kamëntsá of the Sibundoy Valley in Putumayo have used yagé for centuries, with shamanic apprenticeship and plant-medicine gardens documented across the ethnographic literature (Ramírez de Jara & Pinzón Castaño, 1993). The Cofán, A’i Kofán in their own tongue, run yagé ceremonies along the Ecuadorian border. The Siona have what Esther Jean Langdon describes as a revitalized yajé shamanism that survived the rubber period and the violence of the Colombian armed conflict (Langdon, 2016). North of the Amazon, in the Sierra Nevada de Santa Marta, the Kogi and Arhuaco peoples maintain a separate cosmology in which yagé sits inside a wider mamo-led ceremonial system. The Pastos of the Nariño highlands have their own taita lineage at altitude.

The Colombian state recognized indigenous medical knowledge as part of intangible cultural heritage in the late 1990s, which gave taita-led ceremonial practice a layer of constitutional protection that other psychedelic traditions in the Americas would not receive for another two decades (Suárez Álvarez & ICEERS, 2023). In recent years the Inga, Cofán, Siona, Kamëntsá, and Coreguaje have organized through UMIYAC, the Union of Indigenous Yagé Medics of the Colombian Amazon, partly in response to extractive practices outside their territories (Arsenault / UMIYAC, 2020).

A team led by Yuria Celidwen, writing in The Lancet Regional Health Americas, has argued that any Western practice using these medicines carries obligations toward the lineages that hold them (Celidwen et al., 2022). That is not a marketing claim. It is a description of where the medicine came from before any retreat industry existed.

Where to Go: Regional Hubs in Colombia and Peru

Geography is not just scenery here. It is how the medicine arrived.

Peru splits cleanly into two zones. The first is the lowland Amazon around Iquitos, the city you reach only by river or air, where the Shipibo lineage works alongside a dense ecosystem of mestizo-led retreat centers. Long stays of seven, ten, or fourteen days are the standard format. The second is the Sacred Valley near Cusco, where the brew is held within a broader Andean ritual frame that may include Q’ero work, sweat lodges, and altitude-based practices. Cusco runs colder, higher, and drier than Iquitos. The choice between them shapes the whole experience.

Colombia is more distributed. The deepest yagé tradition lives in Putumayo, the southern department on the Ecuadorian border, where the Sibundoy Valley has been the cradle of Inga and Kamëntsá taita training for generations. Most Putumayo ceremonies are tomas: one-night events held in a maloca or community space, opening at sunset and closing before dawn. The format assumes you already understand where you are. Travel to Putumayo is not casual; routes run by air to Mocoa or by road from Pasto.

Medellín, the capital of Antioquia, hosts most of the country’s English-speaking ayahuasca retreat colombia work. Centers operate from the towns ringing the city, including Guarne, Fredonia, and Jardín, within ninety minutes of the international airport at Rionegro. The taitas who lead these ceremonies are typically from Putumayo, Pastos, Cauca, or Kamëntsá communities, traveling north for retreat blocks. The advantage for the first-time traveler is concrete: short ground transfers, professional medical screening, integration support, and access to urban medical infrastructure if anything goes wrong. The cost is that you are a longer flight from the literal river of the lineage.

The Sierra Nevada de Santa Marta, on the Caribbean coast, runs a different system. Kogi and Arhuaco mamos work in their own cosmological frame, and yagé in that frame is one piece of a larger practice rather than the central event of a retreat. Most outsiders meet that work through partner centers near Minca or Palomino rather than directly inside Kogi territory.

Leticia, on the triple border with Brazil and Peru, is the smallest hub and the closest to the Peruvian-style ecosystem. Bogotá itself sees occasional ceremonial activity but is rarely a retreat destination because of altitude and air quality. Where you land in Colombia changes which tradition you meet, and how closely you meet it.

Cost Comparison: What You’ll Actually Pay

Price tracks structure, not value.

Peru and Colombia have priced ayahuasca differently for nearly two decades, and the gap has held. A Shipibo-led seven-day retreat near Iquitos typically lists between $1,800 and $3,500, with longer ten or fourteen-day master-plant dietas running higher. Sacred Valley centers near Cusco sit in a similar band. The pricing covers lodging, meals on the dieta, medical screening, ceremonies, and integration, and it reflects an industry that has been formalizing for twenty years.

Colombia runs cheaper for two structural reasons. The dominant format is shorter; most Colombian ceremonies are one or two nights rather than seven. And the retreat industry is younger, smaller, and less commercialized. A taita-led toma in Putumayo can run $80 to $300 if you travel independently. A two-night retreat in Antioquia at a vetted center, with screening, accommodation, food, and integration, typically runs $400 to $1,200. Multi-day retreats in Colombia, when offered, sit at $900 to $2,500, still meaningfully below Peru’s mid-tier.

What you are paying for in either country is not just the medicine. It is the screening protocol, the dieta supervision, the safety infrastructure, and the integration support that surrounds the ceremonies (ICEERS, 2019). Below a certain price point in either country, those elements start to disappear. That is the most useful number to keep in mind when comparing offers side by side.

Is Ayahuasca Legal in Colombia and Peru?

The law in either country is not what most travelers assume.

Peru placed ayahuasca in its national archive in 2008 when the Instituto Nacional de Cultura issued Resolución Directoral Nacional No. 836, declaring traditional ayahuasca use as Cultural Patrimony of the Nation (INC Peru, Resolución Directoral Nacional No. 836/INC, 2008). The resolution does not legalize ayahuasca for foreign tourists in any general sense. It recognizes the brew within a defined indigenous tradition, and in practice the Peruvian state has not interfered with retreat operators serving foreign visitors as long as that work happens within recognized ceremonial frameworks.

Colombia has no equivalent national resolution. What Colombia has is a constitutional architecture that treats indigenous medical practice as protected cultural patrimony, combined with the absence of any law specifically prohibiting ayahuasca or yagé (Suárez Álvarez & ICEERS, 2023). The result is permissive in practice. Taita-led ceremonies operate openly. Foreign-facing retreats around Medellín, Putumayo, and the Sierra Nevada operate openly. The legal exposure on the ground is closer to zero than in many countries that loudly market their psychedelic legality.

In the United States, DMT remains a Schedule I substance under the Controlled Substances Act (DEA Diversion Control Division, 2024). Brewing ayahuasca, possessing it, or transporting it across the border is a federal offense. The narrow exception, recognized by the Supreme Court in Gonzales v. O Centro Espírita Beneficente União do Vegetal in 2006, applies only to specific religious organizations operating under the Religious Freedom Restoration Act (Gonzales v. O Centro Espírita Beneficente União do Vegetal, 546 U.S. 418, 2006). Most American travelers who drink ayahuasca legally do so by traveling to where the medicine is permitted.

The 1971 UN Convention on Psychotropic Substances, which schedules psychoactive compounds globally, schedules DMT but does not schedule plants containing DMT (UNODC, 1971). That distinction is the hinge on which most national legalities turn.

In 2025 the U.S. Embassy in Lima issued a public health alert advising U.S. citizens not to consume ayahuasca or kambo while in Peru, citing reports of serious adverse events including death (U.S. Embassy Lima, 2025). The alert is not Peruvian regulation. It is a U.S. State Department travel advisory, and travelers should weigh it accordingly.

Safety, Contraindications, and Medical Screening

Most of what people fear about ayahuasca is wrong. What they should fear is something else.

The largest survey of global ayahuasca users to date, with 10,836 participants from more than fifty countries, found that 69.9 percent reported acute physical adverse effects, mostly vomiting and diarrhea, but only 2.3 percent required medical attention, and the great majority of challenging mental experiences were described in retrospect as part of the work rather than as harm (Bouso et al., 2022). That is the baseline you should anchor against when you read alarming stories online.

The actual risks cluster in four zones.

The first is pharmacological. Ayahuasca’s β-carbolines are reversible monoamine oxidase A inhibitors, which is what makes the oral DMT active. The same mechanism makes ayahuasca dangerous to combine with serotonergic medications. SSRIs, SNRIs, MAOIs, tricyclics, lithium, tramadol, MDMA, and St. John’s wort can produce serotonin syndrome when stacked with ayahuasca, and the syndrome can be fatal (Callaway & Grob, 1998). A reputable retreat in either country will require disclosure of all medications and an appropriate washout period before participation (ICEERS, 2024).

The second is cardiovascular. A double-blind placebo-controlled pharmacological study showed that ayahuasca produces dose-dependent increases in systolic and diastolic blood pressure during the acute period, with peak elevations clinically meaningful but transient in healthy adults (Riba et al., 2003). Uncontrolled hypertension, recent cardiac events, and severe arrhythmias are standard exclusions across retreat centers.

The third is psychiatric. A systematic review of psychotic episodes across the ayahuasca literature found rates between 0.0032 percent and 0.096 percent of doses, with most cases occurring in individuals with personal or family histories of psychotic or manic disorders (dos Santos et al., 2017). Active psychosis, schizophrenia, and bipolar I disorder are non-negotiable exclusions for any retreat that screens responsibly.

A consensus list of contraindications now appears across clinical guidelines and harm-reduction protocols (Rossi et al., 2023; ICEERS, 2024). Standard exclusions include:

• Current SSRI, SNRI, MAOI, or other serotonergic medication use without an appropriate medically supervised washout
• Severe cardiovascular disease or uncontrolled hypertension
• Personal history of psychosis or schizophrenia
• Bipolar I disorder or history of mania
• Current pregnancy or breastfeeding
• Severe liver or kidney impairment
• Recent suicidal ideation without psychiatric stabilization

The fourth risk is rarely tabulated in the medical literature but is the most common one in practice: working with an unsafe facilitator. Predatory behavior, poor screening, and inadequate emergency response capacity have been documented in both countries. The retreat’s screening protocol is the single best signal you can read from the outside. Centers that ask many questions about your psychiatric and medical history are signaling something. Centers that do not ask are signaling something different.

How to Choose Between the Two: A Practical Framework

The right country is the one whose format matches what you are actually trying to do.

There is no universal answer to whether Colombia or Peru is the better destination. There is only the question of fit. Six considerations carry most of the weight.

Time available. If you have a week or more and want sustained immersion with multiple ceremonies and a full dieta cycle, Peru’s seven to fourteen-day retreats are built for that work. If you have a long weekend, a Colombian one or two-night format will fit you and a Peruvian retreat will not.

Distance from the lineage. Peru’s Iquitos work is held by Shipibo and mestizo lineages with deep continuity in that watershed. Colombia’s yagé is held by Inga, Cofán, Kamëntsá, Kogi, and Pastos taitas whose continuity stretches further back in the historical record. Both are real. The question is which kind of proximity matters to you.

Format preference. Peruvian work tends to be structured around longer dietas and larger group sizes, often with twenty or more participants. Colombian work is generally smaller and more intimate, with eight to fifteen people in many ceremonies and individual taita attention more available.

Cost. The price gap is consistent across tiers. Colombia is cheaper at every format length.

Travel logistics. Iquitos requires connecting flights through Lima. Cusco requires altitude acclimation. Medellín is a direct flight from much of the United States and Europe. Putumayo and the Sierra Nevada require additional ground time on top of any flight.

The screening conversation. The most reliable signal of a safe retreat in either country is the depth of the screening call. Centers that walk through your medical history, current medications, mental health background, and integration plan before they accept your booking are operating in the right register. The conversation itself is the test.

The decision is rarely about which country is better. It is about which format will hold you while you work.

Share With A Friend

Copied!

You liked what you read. There's more every Tuesday.

No noise. No filler. Just the things worth your attention.

Films Art Culture Real-Life Application Stories

Educational content, documentaries, special events & exclusive offers from MahaDevi Ayahuasca Retreats.

Cold Brew Ayahuasca

Film & Culture

7 Films That Will Transform Your Understanding of Ayahuasca

Documentaries on Amazonian healing — curated by Yasha Shah.

Cold Brew Ayahuasca

A MahaDevi Retreats Newsletter

Three reads this week

Mother Ayahuasca Might Also Be a Father

7 min read · By Yasha Shah

Most who sit with her meet a Mother. The lineages she comes from say there is more.

Every Tuesday

Think clearly.
Feel deeply.
Show up fully.

About the Author

Yasha Shah is the founder of MahaDevi Ayahuasca, a retreat center in Colombia. He has been working with ayahuasca since 2017, with experience across hundreds of ceremonies as both a participant and retreat organizer. Trained within the Shipibo and Camsá traditions, his work bridges indigenous wisdom, harm-reduction principles, and practical integration for modern seekers. Yasha writes about ayahuasca, plant medicine, and psychedelics, covering integration, preparation, and harm reduction to help readers make informed and responsible decisions.

Frequently Asked Questions

Is ayahuasca legal in Colombia?

Yes, in practice. Colombia has no specific legislation prohibiting ayahuasca or yagé, and indigenous medical practice is recognized as protected cultural patrimony under the Constitution. Taita-led ceremonies and foreign-facing retreats operate openly. Travelers should still avoid carrying any brew across borders, since DMT remains scheduled internationally and customs enforcement does not always recognize the plant exemption.

What is the difference between yagé and ayahuasca?

Both are brews built on the Banisteriopsis caapi vine paired with a DMT-containing admixture. In Peru, the admixture is usually Psychotria viridis (chacruna). In Colombia, especially Putumayo and the Vaupés, it is more often Diplopterys cabrerana (chagropanga). The word ayahuasca is Quechua. The word yagé came through Tukanoan and Cofán languages and is standard across Colombian indigenous traditions. The active compounds are the same. The cultural register is different.

How much does an ayahuasca retreat cost in Colombia compared to Peru?

Peru typically runs $700 to $3,500 for three to ten-day retreats, reflecting a mature retreat industry around Iquitos and the Sacred Valley near Cusco. Colombia runs $150 to $2,500 for shorter formats, mostly one to three nights with some longer options. Colombia is cheaper at every tier, partly because the format is shorter and partly because the industry is smaller and less commercialized.

Where in Colombia can you do ayahuasca?

The main hubs are Putumayo (especially the Sibundoy Valley) for the deepest Inga and Kamëntsá yagé tradition, Medellín and surrounding Antioquia for the most accessible English-speaking retreat infrastructure, the Sierra Nevada de Santa Marta for Kogi and Arhuaco-adjacent work, and Leticia in the southern Amazon for proximity to the triple-border ecosystem. Bogotá itself rarely hosts retreats due to altitude and air quality.

Is ayahuasca safe?

In healthy adults without contraindications and within a properly screened ceremonial setting, the safety profile is well-characterized. Acute physical effects, mostly vomiting, are common, but only about 2.3 percent of users in the largest global survey required medical attention. Risks rise sharply with certain medications, certain medical conditions, and certain psychiatric histories. The screening protocol of the retreat is what makes the difference between a safe ceremony and a dangerous one.

Who cannot take ayahuasca?

Standard exclusions across clinical guidelines: current SSRI, SNRI, MAOI, or other serotonergic medication use without medically supervised washout, severe cardiovascular disease or uncontrolled hypertension, personal history of psychosis or schizophrenia, bipolar I disorder or history of mania, current pregnancy or breastfeeding, severe liver or kidney impairment, and recent suicidal ideation without stabilization. Reputable retreats in both Colombia and Peru enforce these exclusions during the screening call.

What should you not mix with ayahuasca?

The dangerous combinations are with serotonergic drugs: SSRIs, SNRIs, tricyclic antidepressants, MAOI antidepressants, lithium, tramadol, MDMA, St. John’s wort, dextromethorphan, and triptan migraine medications. The risk is serotonin syndrome, which can be fatal. Recreational stimulants, alcohol, and most over-the-counter cold medicines are also off-limits in the days before and after ceremony. Disclose every medication and supplement during the screening call.

How long does an ayahuasca ceremony last?

A single ayahuasca ceremony typically runs four to six hours from the first dose. Most ceremonies in both Colombia and Peru begin around sunset and close before midnight, although Putumayo tomas often run later into the night. The full retreat container is much longer: even a one-night Colombian event includes preparation conversations beforehand, the ceremony itself, integration the following morning, and a recovery day on top of travel.

Conclusion

Both countries hold real medicine. Both countries have honest practitioners and predatory ones. Neither is the universal answer.

What is true: Peru built the modern retreat industry, and the Shipibo lineage has shaped what most of the wellness world thinks ayahuasca is. What is also true: Colombia’s yagé traditions are older in the historical record, more plural across regions, and held by communities whose protections under Colombian law are more developed than the global press generally acknowledges.

The first ceremony does not have to be the deepest one. It has to be the safest one in the format that fits what you have time and life-shape for. Most readers researching this question are first-timers. For first-timers, the variables that matter are screening rigor, group size, integration support, and the proximity of medical infrastructure if anything goes wrong. Those variables are available in both countries. They are concentrated in different places.

The vine is the same. The room is not.

References

Arsenault C. (2020). Indigenous Colombians mount a spiritual defense of the Amazon. Mongabay.

Bouso JC, Andión Ó, Sarris J, Scheidegger M, Tófoli LF, Opaleye E, Schubert V, Perkins D. (2022). Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Global Public Health.

Callaway JC, Grob CS. (1998). Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions. Journal of Psychoactive Drugs, 30(4), 367 to 369.

Celidwen Y, Redvers N, Githaiga C, Calambás J, Añaños K, Chindoy ME, Vitale R, Rojas JN, Mondragón D, Rosalío YV, Sacbajá A. (2022). Ethical Principles of Traditional Indigenous Medicine to Guide Western Psychedelic Research and Practice. The Lancet Regional Health – Americas.

Chambers MI, Appley MG, Longo CM, Musah RA. (2020). Detection and Quantification of Psychoactive N,N-Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry. ACS Omega, 5(43).

Drug Enforcement Administration, Diversion Control Division. (2024). N,N-Dimethyltryptamine (DMT): Drug Fact Sheet. U.S. Department of Justice.

dos Santos RG, Bouso JC, Hallak JEC. (2017). Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies. Therapeutic Advances in Psychopharmacology, 7(4), 141 to 157.

Gates B. (1982). Banisteriopsis, Diplopterys (Malpighiaceae). Flora Neotropica Monograph 30. New York Botanical Garden.

Gonzalez D, Cantillo J, Perez I, Carvalho M, Aronovich A, Farre M, Feilding A, Obiols JE, Bouso JC. (2021). The Shipibo Ceremonial Use of Ayahuasca to Promote Well-Being: An Observational Study. Frontiers in Pharmacology, 12.

Gonzales v. O Centro Espírita Beneficente União do Vegetal, 546 U.S. 418 (2006). Supreme Court of the United States.

ICEERS. (2019). Towards Better Ayahuasca Practices: A Guide for Organizers and Participants. International Center for Ethnobotanical Education, Research and Service.

ICEERS. (2024). Ayahuasca Safety Profile. International Center for Ethnobotanical Education, Research and Service.

Instituto Nacional de Cultura, Peru. (2008). Resolución Directoral Nacional No. 836/INC: Declaración del Uso Tradicional de la Ayahuasca como Patrimonio Cultural de la Nación.

Langdon EJ. (2016). The Revitalization of Yajé Shamanism among the Siona: Strategies of Survival in Historical Context. Anthropology of Consciousness, 27(2), 180 to 203.

Ramírez de Jara MC, Pinzón Castaño CE. (1993). Sibundoy Shamanism and Popular Culture in Colombia. In Portals of Power: Shamanism in South America. University of New Mexico Press.

Reichel-Dolmatoff G. (1975). The Shaman and the Jaguar: A Study of Narcotic Drugs Among the Indians of Colombia. Temple University Press.

Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. (2003). Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. Journal of Pharmacology and Experimental Therapeutics, 306(1), 73 to 83.

Rossi G, Reis JCA, Rocha JM, Hallak JEC, Bouso JC, dos Santos RG. (2023). Guidelines for Establishing Safety in Ayahuasca and Ibogaine Administration in Clinical Settings. Psychoactives, 2(4), 373 to 386.

Schultes RE, Raffauf RF. (1992). Vine of the Soul: Medicine Men, Their Plants and Rituals in the Colombian Amazonia. Synergetic Press.

Suárez Álvarez C / ICEERS. (2023). Colombia: Yagé Territory. International Center for Ethnobotanical Education, Research and Service.

United Nations Office on Drugs and Crime. (1971). Convention on Psychotropic Substances, 1971. United Nations.

U.S. Embassy Lima. (2025). Health Alert: Do Not Use Ayahuasca/Kambo. U.S. Department of State, U.S. Mission Lima.